Previous 10 | Next 10 |
Hoth Therapeutics to Initiate IND Enabling Studies of HT-001 Treatment for Cancer Patients PR Newswire NEW YORK , Jan. 11, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced an agreement with Charles River ...
Hoth Therapeutics (HOTH) has entered into a definitive securities purchase agreement in connection with a private placement to institutional investors.The Company expects to receive gross proceeds of ~$5M, not including any proceeds from exercise of warrants. Under the agreement, th...
Hoth Therapeutics Announces Private Placement of Equity Priced At-The-Market Under Nasdaq Rules Definitive Agreement for $5.0 Million in Gross Proceeds PR Newswire NEW YORK , Jan. 5, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharm...
Bionano Genomics (BNGO) -22%.Stable Road Acquisition (SRAC) -12% Momentus updates on 2021 mission, merger with SRAC remains on track to close in Q1.ViewRay (VRAY) -12% after prices equity offering at $4.85.AirNet Technology (ANTE) -11%.TransEnterix (TRXC) -13%.Hall of...
Hoth Therapeutics (HOTH) jumps 15% premarket in reaction to the announcement that its has entered into a Non-Exclusive Commercial Evaluation License Agreement with the U.S. Army Medical Research and Development Command for a new molecular entity ((NME)) developed by the Walter ...
Hoth Therapeutics Announces Licensing Agreement and Collaboration with U.S. Army Medical Research and Development Command (USAMRDC) for Treating Multi-Drug Resistant Bacterial Lung Infections License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Re...
Gainers: Hoth Therapeutics (HOTH) +49%. Bionano Genomics (BNGO) +38%. Clearside Biomedical (CLSD) +17%. Regional Health Properties (RHE) +14%. Ampio Pharmaceuticals (AMPE) +13%.Losers: Histogen (HSTO) -26%. Novan (NOVN) -22%. ORIC Pharmaceuticals (ORIC) -14%. DermTech (DMTK) -12%. T...
Biopharmaceutical company Hoth Therapeutics (HOTH) has signed a production agreement for both GLP and GMP materials associated with HT-001 with Tergus Pharma for its novel cancer treatment. The update follows the recent news that Hoth has requested a Pre-Investigational New Drug ((IND)) meeti...
Ashford (AINC) +75%.PEDEVCO (PED) +62%.SGOCO (SGOC) +49%.Ebang International Holdings (EBON) +33%.Red Lion Hotels RLH +31% on being acquired by Sonesta.Canaan (CAN) +30%.AirNet Technology (ANTE) +25%.Hudson Capital HUSN +24% as FreightHub posts stellar Q3 results.Hoth Ther...
Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment PR Newswire NEW YORK , Dec. 31, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that it has signed a production agreement for both GLP ...
News, Short Squeeze, Breakout and More Instantly...
Hoth Therapeutics Inc. Company Name:
HOTH Stock Symbol:
NASDAQ Market:
Hoth Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment PR Newswire Treatment of pre-clinical subjects showed cognitive benefits that suggest HT-ALZ's mode of action may involve a reduction in brain inflammation, thereby improving cognitiv...